Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Gastroenterology
Reference44 articles.
1. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: Results from the CHARM study;Feagan;Gastroenterology,2008
2. Lymphoma risk and overall safety profile of adalimumab in patients with Crohn's disease with up to 6 years of follow-up in the pyramid registry;D'Haens;Am J Gastroenterol,2018
3. Adalimumab effectiveness up to six years in adalimumab-naïve patients with Crohn's disease: Results of the PYRAMID registry;Loftus;Inflamm Bowel Dis,2019
4. Efficacy and safety of adalimumab by disease duration: Analysis of pooled data from Crohn's disease studies;Panaccione;J Crohns Colitis,2019
5. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: A prospective, multicentre, cohort study;Kennedy;Lancet Gastroenterol Hepatol,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Challenges in IBD Research 2024: Precision Medicine;Inflammatory Bowel Diseases;2024-05-01
2. Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease;Journal of Clinical Medicine;2023-10-27
3. Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease;World Journal of Gastroenterology;2023-05-14
4. Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies;World Journal of Gastroenterology;2023-03-14
5. Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies;World Journal of Gastroenterology;2023-03-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3